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Abstract. Once considered a uniformly fatal condition,
the outlook for newborns with hypoplastic left heart syn-
drome has been dramatically altered with staged recon-
structive procedures. Refinements in operative technique
and perioperative management have been largely respon-
sible for this improved outlook. At the University of
Michigan, 253 patients underwent the Norwood opera-
tion for classic hypoplastic left heart syndrome between
January 1990 and November 1997. Hospital survival was
76%. Among patients considered at standard risk, sur-
vival was significantly higher (86%) than that for those
patients with important risk factors (42%,p 4 0.0001).
Adverse survival was most strongly associated with sig-
nificant associated noncardiac congenital conditions (p
4 0.008) and severe preoperative obstruction to pulmo-
nary venous return (p 4 0.03). Survival following sec-
ond-stage reconstruction with a hemi-Fontan or bidirec-
tional Glenn procedure was 97%. The Fontan procedure
has been completed in 94 of these patients with a hospital
survival rate of 88%. Survival after the Fontan procedure
improved significantly when the second stage of the re-
construction was completed with a hemi-Fontan proce-
dure compared to a bidirectional Glenn (98% vs 81%,p
4 0.05). Among the patients considered at standard risk,
actuarial survival was 70% at 5 years. The largest de-
crease in survival occurred in the first month of life and
late deaths affected primarily those patients in the high-
risk group. Neurodevelopmental outcome studies dem-
onstrated normal verbal and performance scores in the
majority of patients. Staged reconstruction has signifi-
cantly improved the intermediate-term outlook for pa-
tients with hypoplastic left heart syndrome. Factors ad-
dressing improvements in early first-stage survival
would be expected to add significantly to an overall im-
proved late outcome.
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Refinements in operative technique and perioperative
care have been largely responsible for an improved out-
look for newborns with hypoplastic left heart syndrome
(HLHS). Staged reconstruction for patients with HLHS
is based on the knowledge that an effective circulation is
possible in the absence of a pulmonary ventricle. The
principle that pulmonary blood flow could be maintained
when certain well-defined hemodynamic criteria were
met has led to the application of the Fontan procedure to
virtually all forms of single ventricle lesions [7]. The first
stage in the reconstructive process, the Norwood proce-
dure, must provide (1) unobstructed systemic and coro-
nary blood flow from the right ventricle, (2) unobstructed
pulmonary venous return across the atrial septum, and
(3) sufficient pulmonary blood flow without significant
volume overload [14, 20, 21]. This leaves the pulmonary
and systemic circulations in parallel and the right ven-
tricle to perform the increased volume work of both cir-
culations. The second-stage procedure, the hemi-Fontan
or bidirectional Glenn operation, results in removal of
the ventricular volume overload imposed by the systemic
shunt and the connection of the superior vena cava to the
pulmonary arteries [5, 22]. Augmenting the central pul-
monary arteries, preventing conduction disturbances, and
constructing a potential connection for the inferior vena
cava to the pulmonary arteries are considered important
components of this procedure [1, 4]. The hemi-Fontan
procedure, currently preferred to the bidirectional Glenn
at this institution, also allows for the correction of addi-
tional risk factors, including pulmonary artery distortion,
and maintains a stable circulation free of right ventricular
volume overload and pulmonary hypertension. During
the last stage of reconstruction in the Fontan procedure,
inferior vena caval return is channeled to the pulmonary
arteries to complete the separation of the pulmonary and
systemic circulations. Although the current techniques
have resulted in substantial improvements in the quantity
and quality of survival, efforts to refine each stage of the
process continue to evolve with increasing follow-up and
evaluation [4, 12, 18].
Many institutions, initially discouraged by the poor
results of palliative reconstructive surgery for hypoplas-
tic left heart syndrome, abandoned this approach in favor
of transplantation [11, 23]. However, the lack of avail-
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able donor hearts, late complications of cardiac trans-
plantation, and the improvements noted with staged re-
construction have again encouraged an increasing num-
ber of centers in North America and elsewhere to
reevaluate this form of therapy. At the University of
Michigan, we have continued to pursue a policy of of-
fering staged reconstructive surgery for patients with
HLHS. The evolution of our approach and the lessons
learned in this endeavor are presented.
Methods
Initial Management and the Norwood Procedure
The majority of newborns with HLHS are well palliated with an infu-
sion of prostaglandin and reduction of the inspired oxygen concentra-
tion to avoid high systemic arterial saturations, but this condition can-
not be sustained indefinitely and a progressive deterioration in pulmo-
nary function characterized by increasing pulmonary edema will
become evident with time. The presence of significant obstruction to
pulmonary venous return, most commonly resulting from a restrictive
atrial septal defect, will hasten this outcome. In general, when systemic
arterial oxygen saturation is in excess of 80%, peripheral perfusion is
well maintained, and the chest radiograph shows little or no pulmonary
edema, most patients will remain stable and may undergo operation
electively within a few days. However, more significant degrees of
obstruction to pulmonary venous return will result in severe and rapidly
progressive pulmonary edema with systemic arterial oxygen saturations
falling below 75–80%. Urgent intervention is often required before the
pulmonary status deteriorates further. Percutaneous balloon septos-
tomy, often requiring a bioptome to traverse the thickened atrial sep-
tum, has been effective in our laboratory. Operation can then be post-
poned for a few days to allow the pulmonary edema time to resolve. It
has been our experience that optimal results following the Norwood
procedure are obtained when pulmonary blood flow is restricted with
the use of a small shunt [13, 16]. However, satisfactory postoperative
oxygen saturations are increasingly difficult to maintain when a small
shunt is used in a patient with pulmonary edema. A larger shunt will be
required that will often result in pulmonary overcirculation after only a
few hours following cardiopulmonary bypass as the pulmonary edema
and elevated pulmonary vascular resistance resolves. A rapid deterio-
ration in systemic perfusion associated with increasing pulmonary
blood flow may result in hypotension, metabolic acidosis, and death. A
significant diastolic runoff of blood into the pulmonary circulation will
also occur with a large shunt, further adding to low cardiac output from
impaired coronary blood flow due to low diastolic blood pressure [6].
Surgical Technique.Although the method of surgical repair has
remained essentially constant over the past few years, small modifica-
tions have greatly improved the quality of the outcome. These modi-
fications include (1) accurate orientation of the anastomosis between
the ascending aorta and the proximal main pulmonary trunk, (2) aug-
mentation of the descending aorta well beyond the ductus insertion, (3)
improved tailoring of the patch of pulmonary allograft tissue used for
the arch augmentation, and (4) the use of smaller shunts. Cardiopul-
monary bypass is established by cannulation of the proximal main
pulmonary artery just distal to the pulmonary valve and the right atrial
appendage. The branch right and left pulmonary arteries are occluded
and systemic cooling is begun in preparation for circulatory arrest. The
ascending, transverse, and proximal descending segments of the aorta
are mobilized and tourniquets are placed around each head artery for
subsequent occlusion. A cryopreserved pulmonary allograft is trimmed
to fashion a patch that will serve to augment the aorta and allow
anastomosis to the proximal main pulmonary trunk. Following the
induction of circulatory arrest, the atrial septum is excised through the
atrial appendage purse string or a short right atriotomy. The main
pulmonary trunk is then divided at the bifurcation and the distal end
closed with a synthetic patch of GoreTex. The ductal tissue is then
excised completely and the resultant opening is extended approxi-
mately 10 mm further distally into the descending aorta. This incision
is then extended proximally under the transverse arch and down the
diminutive ascending aorta until the level of the previously divided
main pulmonary trunk is reached. The ascending aorta is connected to
the main pulmonary artery with interrupted sutures in the proximal
corner near the coronary arteries and the remainder of the aorta is
augmented with the previously cut pulmonary allograft patch. A 3.5-
mm Gore-Tex conduit is anastomosed from the subclavian or distal
innominate artery to the central pulmonary artery during the rewarming
(Fig. 1). A 4-mm conduit is occasionally used for patients weighing
over approximately 4 kg, those with significantly increased extravas-
cular lung water, or those who are beyond the first month of life. The
distal end of the shunt is placed close to the divided end of the ductus
rather than onto the right pulmonary artery itself.
The Second Stage: Hemi-Fontan Procedure
At the University of Michigan, the hemi-Fontan procedure is preferred
to the bidirectional Glenn because of the capacity to more easily aug-
ment the central pulmonary arteries and to provide a large eventual
connection for the inferior vena cava at the Fontan procedure. Although
more complex, the hemi-Fontan procedure significantly simplifies the
eventual Fontan, at which time optimal hemodynamics and pulmonary
function are most essential to outcome. The hemi-Fontan procedure is
generally performed between 4 and 6 months of age. Cardiac catheter-
ization is routinely performed to assess (1) right ventricular function,
Fig. 1. Reconstruction following the Norwood procedure demonstrates
the shunt, which is positioned between the distal innominate or proxi-
mal subclavian artery and the central pulmonary arteries. Appropriate
tailoring of the allograft patch is essential to avoid excessive dilatation
of the ascending aorta and compression of the left pulmonary artery.
Reprinted with permission from Bove and Mosca [4].
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(2) tricuspid regurgitation, (3) residual arch or pulmonary venous (atrial
septal) obstruction, (4) pulmonary artery anatomy, and (5) pulmonary
vascular resistance. The number of patients with contraindications to
proceeding with the second-stage procedure has been surprisingly few.
Absolute contraindications have included isolated poor right ventricu-
lar function and elevated pulmonary vascular resistance. However,
when decreased right ventricular function exists in association with
another correctable problem, typically residual arch obstruction, exces-
sive volume overload from a large shunt, or tricuspid valve regurgita-
tion, we have proceeded with the hemi-Fontan with the expectation that
ventricular function will improve. The belief that tricuspid valve re-
gurgitation was secondary to volume overload and that it would im-
prove after the second-stage procedure has not proven to be the case,
and we now perform tricuspid valvuloplasty at the hemi-Fontan pro-
cedure when regurgitation is more than mild [24]. Although placement
of the shunt on the central pulmonary artery near the ductal insertion
has resulted in more symmetric growth of the pulmonary arteries fol-
lowing the Norwood procedure, it has been common to find mild
pulmonary artery narrowing at the origin of the left pulmonary artery.
The use of pulmonary allograft patches of smaller widths at the time of
the Norwood procedure has also improved the arch reconstruction and
reduced the incidence of compression of the left pulmonary artery.
Surgical Technique.Cannulation for cardiopulmonary bypass is
accomplished through the distal ascending aorta, placing the arterial
cannula through allograft patch tissue and the venous cannula through
the mid-right atrial wall. The shunt is divided and the pulmonary ar-
teries are mobilized widely. A patch of pulmonary allograft material is
fashioned for augmentation of the pulmonary arteries. The superior
vena cava is mobilized and the azygous vein is ligated. The central
pulmonary arteries are opened beginning beneath the superior vena
cava and extending nearly to the left upper lobe branch (Fig. 2). An
incision is made in the base of the right atrial appendage but is stopped
before its junction with the superior vena cava. This incision has been
modified to avoid injuring the artery to the sinoatrial node. The pul-
monary artery is sutured to the outside wall of the superior vena cava
until the right atrial incision is reached, transferring the suture line to
the atriotomy itself. The pulmonary arteries are then enlarged with the
allograft patch. A separate patch is placed within the right atrium, at the
level of the limbus of the septum secundum, which will isolate superior
vena caval return into the pulmonary arteries and provide an unob-
structed pathway for the connection of inferior vena caval return at the
time of the Fontan procedure. Prior to the insertion of this patch, the
atrial septal defect is inspected and enlarged if necessary. This is best
accomplished by cutting back the coronary sinus into the left atrium. If
indicated, tricuspid valve repair is also performed at this time.
The Third Stage: The Fontan Procedure
The majority of patients following the second-stage reconstruction
have maintained satisfactory palliation for a considerable period of
time [5]. However, some will experience a progressive decline in sys-
t mic arterial oxygen saturation with the development of venovenous
collaterals to the inferior vena caval circulation. Additionally, increas-
ing systemic hypoxemia will be noted in some patients as a result of
increasing growth and activity leading to an increased return of desatu-
rated lower extremity blood with exercise. Even those patients with
azygous continuation of an interrupted inferior vena cava have expe-
rienced a progressive fall in oxygen saturation as venous collaterals
form to the hepatic venous circulation. The development of arteriove-
nous malformations may constitute another important etiology for pro-
gressive hypoxemia in this group [26]. Additionally, chronic hypox-
emia will stimulate growth and development of systemic arterial col-
laterals into the pulmonary circulation resulting in increased volume
overload that may complicate the postoperative course after the Fontan
procedure. For these reasons, the Fontan procedure has generally been
performed at approximately 18 months to 2 years of age. Preoperative
evaluation, including Doppler/echocardiography and cardiac catheter-
ization, is essential to assess ventricular function, atrioventricular valve
regurgitation, pulmonary artery size, pressure and resistance, and the
presence of systemic to pulmonary artery collateral vessels. Major
collaterals should be occluded by coil embolization preoperatively. The
size of the left pulmonary artery is of potential concern following
staged reconstruction for HLHS (Fig. 3). A dilated neoaorta following
the Norwood procedure may cause compression and subsequent hypo-
plasia of the left pulmonary artery. In addition, the low pressure and
reduced flow situation imposed by the hemi-Fontan procedure may
result in a left pulmonary artery of insufficient size for the Fontan.
Insertion of an endoluminal stent at the time of operation has proved to
be a useful adjunct in a few of our patients with otherwise refractory
hypoplasia of the left pulmonary artery. We prefer to utilize stents
Fig. 2. The steps for the second-stage reconstruc-
tion or the hemi-Fontan procedure. The central
pulmonary arteries are opened anteriorly and an
incision is made along the base of the right atrial
appendage (left). A patch is fashioned from a
cryopreserved pulmonary allograft and used to
augment the central pulmonary arteries (right). An
additional patch is placed within the right atrium
to exclude the superior vena cava and the pulmo-
nary arteries from the heart. Although not illus-
trated in this figure, the atrial incision does not
cross the cavoatrial junction to avoid injuring the
artery to the sinoatrial node. Reprinted with per-
mission from Bove and Mosca [4].
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sparingly and, when necessary, to place them at the final procedure
when a larger size stent can be safely inserted.
Surgical Technique.The heart is exposed through a midline ster-
notomy, dissecting adhesions sparingly to avoid injury to the phrenic
nerves. We have not used pericardial substitutes to facilitate reopera-
tion and have found little difficulty with sternal reentry. The majority
of the Fontan procedures were initially performed on continuous car-
diopulmonary bypass with bicaval venous return. However, currently
single venous return is accomplished through the right atrium and the
procedure is done during a brief period of circulatory arrest. The sub-
stantially reduced operative dissection required for this approach has
been possible because of the preliminary connections made at the hemi-
Fontan operation [19]. The entire operative procedure and, in particu-
lar, the cardiopulmonary bypass and aortic cross-clamp times have
been reduced considerably (Table 1). The right atrium is opened and
the previously placed patch between the superior vena cava–pulmonary
artery connection and the right atrium is removed (Fig. 4). A Gore-Tex
patch is then fashioned to channel inferior vena caval return to the
pulmonary arteries (Figs. 5 and 6). An extracardiac conduit has not
been used in our institution except in circumstances in which a lateral
tunnel cannot be constructed (e.g., anomalous pulmonary venous con-
nection and certain heterotaxy syndromes). A fenestration of 4 mm in
diameter has been performed in our institution for all high-risk patients
undergoing the Fontan operation.
Results
A retrospective study was recently performed to evaluate
the outcome of all patients with the diagnosis of HLHS
who presented to C.S. Mott Children’s Hospital, Univer-
sity of Michigan Health System, and underwent first-
stage reconstructive surgery with a Norwood procedure
between January 1990 and August 1995 [3, 15]. In order
to obtain an accurate assessment of the results for those
patients with a single, isolated malformation, only pa-
tients with classic HLHS were included for analysis. For
the purposes of that review, classic HLHS was defined as
a right ventricular-dependent circulation in association
with atresia or severe hypoplasia of the aortic valve.
Therefore, patients with hypoplastic left ventricles but
with an otherwise adequate aortic outflow tract (e.g.,
transposition of the great arteries with mitral atresia)
were excluded, as were patients with aortic atresia or
hypoplasia but with an adequate left ventricle (e.g.,
double-inlet left ventricle with aortic atresia). This was
true even though a Norwood procedure was performed.
Additionally, those patients with double-outlet right ven-
tricle, atrioventricular septal defect, and atrioventricular
discordance were excluded from analysis, except in the
are instance in which both left ventricular and aortic
Fig. 3. Angiogram performed with contrast injected into the superior
vena cava following the hemi-Fontan procedure. Unobstructed pulmo-
nary arteries are visualized and no contrast enters the right atrium.
Reprinted with permission from Bove and Mosca [4].










Bidirectional Glenn 111 ± 32 59 ± 19
Hemi-Fontan 56 ± 10 39 ± 8
Fig. 4. The Fontan procedure is performed by first removing the pre-
viously inserted patch beneath the superior vena caval–pulmonary ar-
tery connection. The coronary sinus is cut back to enlarge the atrial
septal defect if necessary (insert). Reprinted with permission from
Bove and Mosca [4].
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atresia or hypoplasia existed together. Patients in the
study were divided into ‘‘standard-risk’’ and ‘‘high-
risk’’ groups according to certain predefined criteria es-
tablished from prior analyses performed at this institu-
tion [13, 15].
Definition of Risk Groups
In order to define the high-risk population, patients pre-
senting with coexisting conditions known to affect out-
come were considered as a separate group. Considered
among the high-risk group were patients undergoing the
Norwood procedure beyond the first month of life and
those presenting with severe obstruction to pulmonary
venous return. The latter was defined as the occurrence
of severe hypoxemia in conjunction with radiographic
evidence of pulmonary edema and an intact or nearly
intact atrial septum confirmed by Doppler/echo-
cardiography and by direct surgical or pathologic inspec-
tion. Finally, patients with significant noncardiac con-
genital conditions that were judged to affect or poten-
tially affect prognosis were also excluded from the
standard-risk group. Such conditions included prematu-
rity (<35 weeks’ gestational age), low birth weight (<2.5
kg), chromosomal anomalies, and major noncardiac
anomalies such as diaphragmatic hernia. The remaining
patients were considered at standard risk, but this group
was anatomically diverse and, therefore, patients with
coexisting anomalies of the ventricular or atrioventricu-
lar septum, visceroatrial situs defects, or atrioventricular
discordance were analyzed separately. Patients were not
excluded for systemic or pulmonary venous or arterial
anomalies. Because prior reports from this institution
failed to identify the specific morphologic subgroup (i.e.,
aortic atresia and mitral atresia, aortic atresia and mitral
hypoplasia, aortic hypoplasia and mitral atresia, and aor-
tic hypoplasia and mitral hypoplasia) as a risk factor, no
further anatomic subdivision of the standard-risk group
was undertaken for the current analysis. Patients were
not stratified by preoperative condition. Therefore, the
standard-risk group was composed of patients with typi-
cal HLHS, including those with minor anatomic variants,
who underwent primary Norwood operation within the
first month of life and who did not have severe obstruc-
tion to pulmonary venous return or significant noncar-
diac conditions. All other patients were analyzed in the
high-risk group.
Fig. 5. A polytetrafluoroethylene patch is used to
channel inferior vena caval return to the previ-
ously constructed anastomosis with the pulmonary
arteries. Alternatively, the patch may be cut from
a conduit opened along one side (left). The exter-
nal position of the snare surrounding the fenestra-
tion is shown (right). Reprinted with permission
from Bove and Mosca [4].
Fig. 6. Angiogram performed after the Fontan procedure demonstrat-
ing the completed cavopulmonary connection. A streamlined pathway
from the inferior vena cava is shown. Reprinted with permission from
Bove and Mosca [4].
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Clinical Data
Between January 1990 and November 1997, 253 patients
with classic HLHS underwent a Norwood procedure at
the University of Michigan, exclusive of those patients
undergoing Norwood procedures for other single ven-
tricle lesions with systemic outflow tract obstruction. A
detailed analysis of the first 158 of these patients oper-
ated upon between January 1990 and August 1995 was
previously reported [3]. Between September 1995 and
November 1997, an additional 95 patients with the clas-
sic form of HLHS, both standard and high risk, under-
went the Norwood procedure at our institution, bringing
the total to 253 patients. Hospital survival for this latter
group has been identical to that of patients in the previ-
ous study. Because long-term analysis is not yet avail-
able for these recent patients and their outcomes appear
to be no different from those of the earlier group, the data
reported here are from our prior report.
Survival
Of the 158 patients undergoing the Norwood procedure,
there were 120 hospital survivors [76%; 70% confidence
limit (CL70), 72–79%). Of note, hospital survival for the
most recent 95 patients not included in the earlier review,
both standard and high risk, was 75%. Hospital survival
was significantly better among the 127 standard risk pa-
tients (86%; CL70, 82–89%) when compared to those in
the high-risk group (42%; CL70, 33–51%;p 4 0.0001).
Patients were excluded from the standard-risk group be-
cause of associated noncardiac congenital conditions in
17, severe pulmonary venous obstruction in 8, and age
beyond 1 month at initial surgical intervention in 6. Fur-
ther analysis of the high-risk group revealed that hospital
survival following the Norwood procedure was signifi-
cantly worse among those patients with significant non-
cardiac congenital conditions (p 4 0.008) and in those
with severe obstruction to pulmonary venous return (p 4
0.03).
There were 106 hemi-Fontan procedures performed
with 103 hospital survivors (97%; CL70, 95–98%).
There was 1 late death. Three of the survivors are not
considered to be candidates for the Fontan procedure
because of neurologic dysfunction (pre-Norwood), pul-
monary artery distortion unresponsive to surgical repair
and endoluminal stenting, and right ventricular dysfunc-
tion following an influenza-like illness, respectively. The
latter patient has undergone successful cardiac transplan-
tation.
In a report from this institution, the outcome of the
94 patients in the group following the Fontan procedure
was reviewed [17]. Overall survival was 88% [95% con-
fidence limit (CL95); 81–94%]. Survival was signifi-
cantly better among the 42 patients who underwent a
preliminary hemi-Fontan operation (98%; CL95, 88–
100%) when compared to those undergoing a bidirec-
ional Glenn procedure (81%; CL95, 76–86%;p < 0.05).
The largest decrease in survival occurred in the first
month of life. Losses among survivors of the Norwood
procedure prior to or related to the hemi-Fontan proce-
dure affected primarily the high-risk group and deaths
occurring during the second and third year of life were
primarily due to hospital death following the Fontan op-
eration. The latter was due primarily to unrecognized
stenosis or hypoplasia of the left pulmonary artery and
occurred early in our experience before routine use of the
hemi-Fontan procedure. Survival at 1 month, 1 year, and
5 years for the 127 patients considered at standard risk
and with typical anatomy was 85 ± 4%, 80 ± 5%, and 69
± 8%, whereas survival for those with anatomic variants
was 86 ± 11%, 71 ± 17%, and 71± 17%, respectively.
Survival for high-risk patients was 61 ± 14%, 20 ± 40%,
and 20 ± 40% at 1 month, 1 year, and 2 years, respec-
tively.
Morbidity
Significant or potentially significant harmful conditions
were noted in 25 of the 120 hospital survivors (21%;
CL70, 17–25%). Morbidity related to the cardiovascular
system was noted in 12 patients (10%; CL70, 8–13%).
Harmful conditions included dysrhythmias in 5 patients
(3 with permanent pacemakers, 1 with supraventricular
tachycardia requiring amiodarone, and 1 with sick sinus
syndrome), left pulmonary artery occlusion in 4 patients
(patency restored in 3), chronic pleural effusions in 2,
pulmonary artery hypertension requiring oxygen therapy
in 1 patient in whom both the Norwood and hemi-Fontan
procedures were performed after awaiting a transplant
for 7 months at another institution, and dilated cardio-
myopathy requiring transplantation at age 27 months in 1
patient. One patient had both dysrhythmias and pulmo-
nary artery occlusion. Mechanical ventilation was re-
quired in 4 patients, with only 1 late survivor. Hemidia-
phragm paralysis was noted in 7 patients, 6 of whom
underwent plication.
Neurodevelopmental Outcome
Late neurodevelopmental outcome was assessed in 49
patients following the Fontan procedure in a recent study
from our institution [10]. Wechsler Preschool and Pri-
mary Scales of Intelligence-Revised were used for pa-
tients between 34 and 72 months of age and Wechsler
Intelligence Scales for Children for those between 73 and
96 months. Mean verbal, performance, and overall test
scores were normal for the 25 patients in this study with
HLHS, although scorers were slightly lower than those
313Bove: Status of Staged Reconstruction
of patients with other single ventricle lesions. For both
groups, verbal and communication skills were signifi-
cantly and consistently better than motor and perfor-
mance skills.
Discussion
The term hypoplastic left heart syndrome, first used by
Hauck and Nadas in 1958, has remained a clinically use-
ful description of a constellation of cardiac malforma-
tions all characterized by underdevelopment or the ab-
sence of the left ventricle. The ability to make a precise
diagnosis in the newborn and the introduction of prosta-
glandin E1 to maintain patency of the ductus arteriosus to
support the systemic circulation allowed the develop-
ment of palliative surgical approaches. The majority of
babies with HLHS are otherwise normal newborns. Only
5% are premature or small for gestational age. Noncar-
diac malformations coexist in 12% and are major in only
2% or 3%. Without treatment, 95% die within the first
month of life. The postnatal physiology is characterized
by an obligatory left to right shunt at atrial level and the
need for the right ventricle to supply both the parallel
systemic and pulmonary circulations [10]. The coronary
and brachiocephalic vessels are perfused in a retrograde
fashion. Alteration in hemodynamic status is determined
by three major factors: (1) the expected fall in pulmonary
vascular resistance, (2) constriction of the ductus arte-
riosus, (3) and the adequacy of the atrial communication.
Stabilization of the newborn with HLHS is, conse-
quently, dependent on the status and/or ability to favor-
ably influence these factors.
There is no doubt that staged reconstruction now
offers survival for patients with HLHS that equals that
currently reported for many other forms of complex con-
genital cardiac malformations. In our series, the actuarial
survival rate, including hospital death for each operative
procedure, for those patients considered at standard risk
is approximately 70% at 5 years. These data compare
favorably to those for patients with other forms of single
ventricle, pulmonary atresia with intact ventricular sep-
tum, and even for some complex forms of tetralogy of
Fallot. High-risk patients, on the other hand, did not fare
as well. For these patients, it may be reasonable to con-
clude that cardiac transplantation should be offered in-
stead of staged reconstruction. However, the often grave
and unstable condition of most of these patients would
clearly preclude them from transplantation as a viable
option. In an effort to improve the results among this
group of patients, those presenting with severe obstruc-
tion to pulmonary venous return now undergo prelimi-
nary atrial septectomy, either percutaneous or operative,
and the Norwood procedure is postponed until evidence
of diminished pulmonary vascular resistance and lung
fields free of edema are seen. Patients below 2.5 kg in
weight often receive a standard Blalock–Taussig shunt
which appears to limit pulmonary blood flow to a more
appropriate degree and is better tolerated in very small
birth weight babies. Because the greatest risk for death
occurs during the first month of life, efforts to reduce
perioperative Norwood mortality would be expected to
result in improved late survival. Survival following the
hemi-Fontan procedure has been excellent and late sud-
den death unrelated to subsequent operations has been
rare. Additionally, mortality associated with the Fontan
procedure occurred almost entirely with the earliest
group of patients coming to the third stage. This risk has
been substantially reduced in recent patients.
It is often difficult to be certain that postoperative
neurologic and/or cardiovascular conditions are a result
of any given operation or intervention because many of
these patients were gravely ill upon presentation and
prior to any procedures [8, 9, 25]. Nonetheless, previous
attempts to correlate preoperative condition to outcome
failed to reveal an association and many patients who
were moribund prior to their Norwood procedure
achieved excellent late results [13]. The effects of the
operative procedures, including the use of deep hypo-
thermia and circulatory arrest, are unclear but are cur-
rently undergoing detailed evaluation. In a recent report
from our institution, Goldberg and colleagues [10] found
that neurodevelopmental outcome was normal in the ma-
jority of patients evaluated after the Fontan procedure.
Although the group of patients with HLHS fared slightly
less well than other patients with single ventricle lesions,
most remained within the normal range. Morbidity re-
lated to the cardiovascular and respiratory systems will
undoubtedly always be a part of these complex surgical
interventions, but the modifications noted earlier have
significantly reduced their impact.
Conclusions
Staged reconstruction for neonates born with HLHS of-
fers a viable form of treatment with a good intermediate-
term outcome. Survival has substantially improved and
morbidity surrounding various interventions has been
significantly reduced. Although it appears that most sur-
vivors grow and develop normally, it is essential to con-
tinually evaluate these patients to assess late quality of
life. Current efforts aimed at reducing mortality follow-
ing the Norwood operation by providing a more stable
circulation and at eliminating the risk factors for the
Fontan procedure are expected to result in continued im-
provements in late survival.
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